🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:
ВВЕРХ
#THOR +167% Synthorx, Inc. -company announced it would be acquired by Sanofi for $68 per share in cash.
#XBIT +149% XBiotech Inc. - the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.
#ARQL +102% ArQule, Inc. - the company agreed to be acquired by Merck & Co., Inc. #MRK for $20 per share in cash.
#OBSV +51% ObsEva SA - after reporting positive results from uterine fibroids Phase 3 study (PRIMROSE 2) of linzagolix.
#FATE +26% Fate Therapeutics, Inc. - the company disclosed that combination of FT596 with rituximab showed durable tumor clearance in vivo in preclinical lymphoma model at the ASH 2019.
#TGTX +24% TG Therapeutics, Inc. - the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.
#PCG +21% PG&E Corporation - the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.
#KRMD +12% Repro Med Systems, Inc.
#RRTS +11% Roadrunner Transportation Systems, Inc. - reported the sale of its Flatbed Business unit for $30 million in cash.
#SMLP +11% Summit Midstream Partners, LP
#FNV +8% Franco-Nevada Corporation
#BLUE +6% bluebird bio, Inc. - presented new data from ongoing Phase 1/2 HGB-206 study of LentiGlobin gene therapy for sickle cell disease at the ASH 2019.
#LPL +6% LG Display Co., Ltd.
ВНИЗ
#DPLO -32% Diplomat Pharmacy, Inc. -UnitedHealth Group Inc
#UNH announced plans to buy Diplomat Pharmacy for around $300 million.
#KALV -30% KalVista Pharmaceuticals, Inc. - the company disclosed that its Phase 2 trial of KVD001 did not meet its primary endpoint.
#DDOG -4% Datadog, Inc.
#KOS -4% Kosmos Energy Ltd
#DRIO -4% DarioHealth Corp.
#TGT -3% Target Corporation
#RDHL -3% RedHill Biopharma Ltd.
премаркет США - акции - заметные движения:
ВВЕРХ
#THOR +167% Synthorx, Inc. -company announced it would be acquired by Sanofi for $68 per share in cash.
#XBIT +149% XBiotech Inc. - the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.
#ARQL +102% ArQule, Inc. - the company agreed to be acquired by Merck & Co., Inc. #MRK for $20 per share in cash.
#OBSV +51% ObsEva SA - after reporting positive results from uterine fibroids Phase 3 study (PRIMROSE 2) of linzagolix.
#FATE +26% Fate Therapeutics, Inc. - the company disclosed that combination of FT596 with rituximab showed durable tumor clearance in vivo in preclinical lymphoma model at the ASH 2019.
#TGTX +24% TG Therapeutics, Inc. - the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.
#PCG +21% PG&E Corporation - the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.
#KRMD +12% Repro Med Systems, Inc.
#RRTS +11% Roadrunner Transportation Systems, Inc. - reported the sale of its Flatbed Business unit for $30 million in cash.
#SMLP +11% Summit Midstream Partners, LP
#FNV +8% Franco-Nevada Corporation
#BLUE +6% bluebird bio, Inc. - presented new data from ongoing Phase 1/2 HGB-206 study of LentiGlobin gene therapy for sickle cell disease at the ASH 2019.
#LPL +6% LG Display Co., Ltd.
ВНИЗ
#DPLO -32% Diplomat Pharmacy, Inc. -UnitedHealth Group Inc
#UNH announced plans to buy Diplomat Pharmacy for around $300 million.
#KALV -30% KalVista Pharmaceuticals, Inc. - the company disclosed that its Phase 2 trial of KVD001 did not meet its primary endpoint.
#DDOG -4% Datadog, Inc.
#KOS -4% Kosmos Energy Ltd
#DRIO -4% DarioHealth Corp.
#TGT -3% Target Corporation
#RDHL -3% RedHill Biopharma Ltd.
December 9, 2019